相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Systemic PEGylated TRAIL Treatment Ameliorates Liver Cirrhosis in Rats by Eliminating Activated Hepatic Stellate Cells
Yumin Oh et al.
HEPATOLOGY (2016)
CD146 promotes metastasis and predicts poor prognosis of hepatocellular carcinoma
Guoqing Jiang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
The Efficacy of Continued Sorafenib Treatment after Radiologic Confirmation of Progressive Disease in Patients with Advanced Hepatocellular Carcinoma
Yoshiyuki Wada et al.
PLOS ONE (2016)
Targeting adeno-associated virus and adenoviral gene therapy for hepatocellular carcinoma
Yi-Gang Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Safety and antitumor effect of oncolytic and helper-dependent adenoviruses expressing interleukin-12 variants in a hamster pancreatic cancer model
J. Poutou et al.
GENE THERAPY (2015)
Potent and long-term antiangiogenic efficacy mediated by FP3-expressing oncolytic adenovirus
Il-Kyu Choi et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Oncolytic Newcastle disease virus expressing chimeric antibody enhanced anti-tumor efficacy in orthotopic hepatoma-bearing mice
Ding Wei et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
Progress in clinical oncolytic virus-based therapy for hepatocellular carcinoma
Adel H. Jebar et al.
JOURNAL OF GENERAL VIROLOGY (2015)
Going viral: a review of replication-selective oncolytic adenoviruses
Christopher Larson et al.
ONCOTARGET (2015)
New insights into IL-12-mediated tumor suppression
S. Tugues et al.
CELL DEATH AND DIFFERENTIATION (2015)
Advances in the Pharmacologic Treatment of Hepatocellular Carcinoma
Neil H. Bhayani et al.
CURRENT CLINICAL PHARMACOLOGY (2015)
TRAIL negatively regulates VEGF-induced angiogenesis via caspase-8-mediated enzymatic and non-enzymatic functions
Hee-Jun Na et al.
ANGIOGENESIS (2014)
Interleukin 12: still a promising candidate for tumor immunotherapy?
Witold Lasek et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Getting TRAIL back on track for cancer therapy
J. Lemke et al.
CELL DEATH AND DIFFERENTIATION (2014)
Adenovirus Vectors for Gene Therapy, Vaccination and Cancer Gene Therapy
William Wold et al.
CURRENT GENE THERAPY (2014)
Oncolytic viruses as anticancer vaccines
Norman Woller et al.
FRONTIERS IN ONCOLOGY (2014)
Activated monocytes augment TRAIL-mediated cytotoxicity by human NK cells through release of IFN-γ
Dhifaf Sarhan et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Recent advances in delivery of drug-nucleic acid combinations for cancer treatment
Jing Li et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Oncolytic viruses as therapeutic cancer vaccines
David L. Bartlett et al.
MOLECULAR CANCER (2013)
IL-27 Enhances the Expression of TRAIL and TLR3 in Human Melanomas and Inhibits Their Tumor Growth in Cooperation with a TLR3 Agonist Poly(I:C) Partly in a TRAIL-Dependent Manner
Yukino Chiba et al.
PLOS ONE (2013)
Dendritic Cells in the Cancer Microenvironment
Yang Ma et al.
JOURNAL OF CANCER (2013)
Synergistic antitumor effect of TRAIL and IL-24 with complete eradication of hepatoma in the CTGVT-DG strategy
Ying Cai et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2012)
Evolution of oncolytic adenovirus for cancer treatment
Joung-Woo Choi et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Gene-viro-therapy targeting liver cancer by a dual-regulated oncolytic adenoviral vector harboring IL-24 and TRAIL
X. Liu et al.
CANCER GENE THERAPY (2012)
A conditionally replicating adenovirus carrying interleukin-24 sensitizes melanoma cells to radiotherapy via apoptosis
Guan Jiang et al.
MOLECULAR ONCOLOGY (2012)
New frontiers in promoting tumour cell death: targeting apoptosis, necroptosis and autophagy
J. S. Long et al.
ONCOGENE (2012)
Active targeting of RGD-conjugated bioreducible polymer for delivery of oncolytic adenovirus expressing shRNA against IL-8 mRNA
Jaesung Kim et al.
BIOMATERIALS (2011)
Oncolytic Adenoviruses for the Treatment of Human Cancer: Focus on Translational and Clinical Data
Sari Pesonen et al.
MOLECULAR PHARMACEUTICS (2011)
Advances in Viral Vector-Based TRAIL Gene Therapy for Cancer
Lyse Norian et al.
Cancers (2011)
A Hypoxia- and α-Fetoprotein-Dependent Oncolytic Adenovirus Exhibits Specific Killing of Hepatocellular Carcinomas
Oh-Joon Kwon et al.
CLINICAL CANCER RESEARCH (2010)
Therapeutic and Tumor-specific Immunity Induced by Combination of Dendritic Cells and Oncolytic Adenovirus Expressing IL-12 and 4-1BBL
Jing-Hua Huang et al.
MOLECULAR THERAPY (2010)
Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients
Lun Cai et al.
CLINICAL IMMUNOLOGY (2008)
Short hairpin RNA-expressing oncolytic adenovirus-mediated inhibition of IL-8: effects on antiangiogenesis and tumor growth inhibition
J. Y. Yoo et al.
GENE THERAPY (2008)
Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model
Young-Sook Lee et al.
CLINICAL CANCER RESEARCH (2006)
TRAIL-induced cell death cooperates with IFN-γ activation in the graft-versus-tumor effect against colon tumors
K Tateishi et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Preclinical differentiation between apparently safe and potentially hepatotoxic applications of TRAIL either alone or in combination with chemotherapeutic drugs
TM Ganten et al.
CLINICAL CANCER RESEARCH (2006)
Oncolytic replication-competent adenovirus suppresses tumor angiogenesis through preserved E1A region
Y Saito et al.
CANCER GENE THERAPY (2006)
A novel dendritic cell subset involved in tumor immunosurveillance
J Taieb et al.
NATURE MEDICINE (2006)
Regulation of dendritic cell function by NK cells: Mechanisms underlying the synergism in the combination therapy of IL-12 and 4-1BB activation
PY Pan et al.
JOURNAL OF IMMUNOLOGY (2004)
TRAIL inhibits tumor growth but is nontoxic to human hepatocytes in chimeric mice
CH Hao et al.
CANCER RESEARCH (2004)
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon γ-dependent natural killer cell protection from tumor metastasis
MJ Smyth et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)